Find policies, billing codes, payers, states, and providers
Bariatric (weight loss) surgery — coverage criteria
Customize your policy alerts
Sign up for Premera Bluecross Policy 7.01.516 alerts
Get alerted when Policy 7.01.516 changes without checking for updates manually.
Monitor payer policy activity
Defines medical necessity, coverage criteria, documentation, and coding considerations for primary, revision, and conversion bariatric procedures for adults and adolescents when benefits exist under the member's contract.
No material clinical or coverage changes in this revision.
Coverage Criteria for Bariatric Surgery
Primary bariatric surgery for adults (class II/III obesity and T2 diabetes)
Covered when ALL of the following are met:
Asian-specific BMI cutpoints are specified
Revision, conversion, and reoperation criteria
Revision or conversion bariatric surgery may be considered medically necessary when addressing complications or inadequate weight loss and ALL relevant conditions are met:
Noncompliance with postoperative nutrition and exercise is not a valid indication for revision/conversion.
Investigational and not medically necessary procedures
The following procedures are considered investigational or not medically necessary:
Procedures considered not medically necessary by BMI
Selection and preoperative criteria
Covered when ALL of the following are met (selection criteria and preoperative requirements as described):
Adults with Class III Obesity
Covered when criteria and evidence support benefit in adults with class III obesity
Evidence (RCTs, observational studies, SOS study) shows substantial weight loss and improved outcomes with bariatric surgery.
Adults with Class II and III Obesity
Covered when evidence indicates improved net health outcome for adults meeting BMI criteria
Evidence sufficient to determine improvement in net health outcome.
Evidence sufficient to determine improvement in net health outcome.
Adults with Class I Obesity and Type 2 Diabetes
Covered when criteria include inadequate glycemic control despite optimal therapy
Systematic reviews show greater diabetes remission and HbA1c reduction with surgery; evidence quality rated low to very low but net benefit considered.
Adults with BMI <35 without Type 2 Diabetes
Not covered / insufficient evidence
Evidence is insufficient to determine improvement in net health outcome for this population.
Adolescents with Obesity
Covered with caution and additional criteria
Guidelines recommend reserving surgery for severe cases and ensuring long-term follow-up and multidisciplinary care.
Revision Bariatric Surgery
Covered when clinically indicated
Systematic reviews and registry data show generally satisfactory outcomes and acceptable complication profile.
Hiatal Hernia Repair with Bariatric Surgery
Covered when hiatal hernia is diagnosed preoperatively
Evidence shows better GERD remission and fewer complications when repair is performed for preoperatively diagnosed hernia; no evidence to support repair for incidental findings.
Esophagogastroduodenoscopy (EGD) with Bariatric Surgery
Selective coverage; routine preoperative EGD not clearly supported
Systematic reviews found only about 20% of preoperative EGDs identified findings that altered operative management; evidence insufficient to support routine EGD for all candidates.
Adolescent candidate selection
Guideline-recommended criteria for considering metabolic and bariatric surgery in children and adolescents:
ASMBS position statement; multidisciplinary evaluation required
Endocrine Society (with Pediatric Endocrine Society/European Society of Endocrinology update)
EGD pre/postoperative guidance
ASMBS position on upper GI endoscopy for bariatric patients:
Findings may or may not change management; identifies conditions that impact procedure selection
Regulatory and device safety considerations
FDA-approved implantable bariatric devices and safety communications:
Coverage should align with device labeling and documented failure of supervised programs
Notable criteria updates
Policy statements and criteria have been updated over time; notable recent changes include:
Routine liver biopsy performed incident to bariatric or obesity surgery is not medically necessary when there are no preoperative signs or symptoms of liver disease. Documentation should show clinical indications (for example, persistently elevated liver enzymes or an enlarged liver) to justify intraoperative liver biopsy; absent those findings routine sampling is considered noncovered.
Preoperative esophagogastroduodenoscopy (EGD) is not required universally for all bariatric surgery candidates. The American Society for Metabolic and Bariatric Surgery (ASMBS) recommends preoperative EGD only for individuals with upper gastrointestinal symptoms, while also noting that routine EGD may be performed at the surgeon’s discretion because some asymptomatic abnormalities can be identified; when EGD is performed, providers should document the clinical indication, findings, and how the results influenced surgical planning.
Vertical-banded gastroplasty (VBG, CPT 43842) is largely a historical procedure in the United States and is no longer an ASMBS‑endorsed option. Due to high long‑term revision and reoperation rates, VBG is not routinely performed and is listed in the policy as not medically necessary for class III obesity.
Bariatric surgery is considered not covered / not medically necessary for adults with BMI <35 kg/m2 who do not have type 2 diabetes. The evidence for benefit in lower‑BMI adults without T2D is insufficient to determine net health outcome improvements, and the policy does not support routine coverage in this population.
Historically, the Centers for Medicare & Medicaid Services (CMS) National Coverage Determination (2006) concluded that certain procedures are noncovered for Medicare beneficiaries; specifically, open and laparoscopic sleeve gastrectomy and open adjustable gastric banding were listed as noncovered procedures for all Medicare beneficiaries in that decision memo.
The references section includes clinical studies and reviews of endoscopic and novel device–based therapies (for example, intragastric balloons, EndoBarrier, and other endoscopic techniques). Inclusion of these references is for background and evidence review; the reference list by itself does not establish coverage determinations beyond the explicit policy statements identifying investigational or not medically necessary procedures.
This medical policy and its coverage statements do not apply to Medicare Advantage plans. Providers and members should consult the member benefit booklet or contact customer service for plan‑specific coverage rules and limitations.
Vertical-banded gastroplasty is explicitly characterized in the policy as not medically necessary for class III obesity. In addition, the policy indicates bariatric surgery is not medically necessary for populations not meeting the documented BMI thresholds (for example, adults with BMI <35 kg/m2 without T2D and other low‑BMI groups) unless otherwise specified by Asian‑specific thresholds or other policy exceptions.
Adjustable gastric banding may be less appropriate for individuals with very high baseline body mass (for example, BMI ≥50 kg/m2) because available data indicate it generally yields less weight loss than other procedures; procedure selection should reflect individual goals and the evidence on expected weight loss.
ASMBS guidance and the policy emphasize that routine preoperative EGD for asymptomatic individuals is not routinely recommended; preoperative EGD should be performed for patients with relevant symptoms or other clinical indications, and when performed the indication and findings should be documented to support how results affected surgical planning.
Procedures performed in populations with insufficient evidence—such as adults with BMI <35 kg/m2 without type 2 diabetes and preadolescent children—are considered not medically necessary in this policy due to inadequate evidence demonstrating net health benefit. Coverage decisions require meeting the policy’s documented selection criteria and evidence thresholds.
Professional society guidance recommends against offering bariatric surgery to preadolescent children and to pregnant or breastfeeding adolescents, and advises caution for those planning pregnancy within two years of surgery. These recommendations are reflected in the policy’s statements and are part of the considerations used to decline surgery when appropriate.
The policy’s reference list contains multiple studies and systematic reviews of endoscopic and device‑based therapies; however, citing these studies in the references does not by itself alter coverage positions—coverage determinations are made according to the explicit investigational, medically necessary, and not medically necessary statements in the policy.
Historically, vertical‑banded gastroplasty was reclassified from medically necessary to not medically necessary in prior policy updates; other procedures have also been moved between coverage categories over time as noted in the policy history and update notes.
Procedure Codes and Coding Notes
| 43845 | Biliopancreatic bypass with duodenal switch (open) |
| 43659 | Unlisted laparoscopy procedure, bariatric revisions/other (used for duodenal switch laparoscopic?) |
| 43644 | Laparoscopic gastric bypass (Roux-en-Y) — CPT listed in policy |
| 43645 | Open gastric bypass (Roux-en-Y) — CPT listed in policy |
| 43846 | Gastric bypass (Roux-en-Y) short limb (≤150 cm) |
| 43770 | Laparoscopic adjustable gastric banding (e.g., LAP-BAND, REALIZE) |
| 43775 | Sleeve gastrectomy |
| 43999 | Unlisted procedure, stomach (used for SADI-S listed as 43999) |
| 43843 | Laparoscopic gastric plication (LGCP) |
| 43842 | Vertical-banded gastroplasty (VBG) |
| 43847 | Long-limb gastric bypass procedure (>150 cm) — investigational |
| 43889 | Endoscopic sleeve gastroplasty (ESG) — investigational |
| 0813T | Spatz3 intragastric balloon (example NCCI/HCPCS adjunct listed) |
| C9785 | Transoral outlet reduction endoscopy (TORe) — HCPCS code cited as investigational |
| 43633 | Open sleeve gastrectomy (policy notes CPT 43633 is for open procedure) |
| 0813T | Esophagogastroduodenoscopy, flexible, transoral, with volume adjustment of intragastric bariatric balloon (e.g., Spatz3). |
| 43290 | Esophagogastroduodenoscopy, flexible, transoral; with deployment of intragastric bariatric balloon. |
| 43291 | Esophagogastroduodenoscopy, flexible, transoral; with removal of intragastric bariatric balloon(s). |
| 43644 | Laparoscopy, surgical, gastric restrictive procedure; with gastric bypass and Roux-en-Y gastroenterostomy (roux limb 150 cm or less). |
| 43645 | Laparoscopy, surgical, gastric restrictive procedure; with gastric bypass and small intestine reconstruction to limit absorption |
| 43659 | Unlisted laparoscopy procedure, stomach / Laparoscopy, surgical, gastric restrictive procedure; placement of adjustable gastric. |
| 43772 | Laparoscopy, surgical, gastric restrictive procedure; removal of adjustable gastric restrictive device component only. |
| 43773 | Laparoscopy, surgical, gastric restrictive procedure; removal and replacement of adjustable gastric restrictive device component only. |
| 43774 | Laparoscopy, surgical, gastric restrictive procedure; removal of adjustable gastric restrictive device and subcutaneous port components. |
| 43775 | Laparoscopy, surgical, gastric restrictive procedure; longitudinal gastrectomy (i.e., sleeve gastrectomy). |
| 43842 | Gastric restrictive procedure, without gastric bypass, for morbid obesity; vertical-banded gastroplasty. |
| 43843 | Gastric restrictive procedure, without gastric bypass, for morbid obesity; other than vertical-banded gastroplasty. |
| 43845 | Gastric restrictive procedure with partial gastrectomy, pylorus-preserving duodenoileostomy and ileoileostomy (50 to 100 cm common channel) to limit absorption (biliopancreatic diversion with duodenal switch). |
| 43846 | Gastric restrictive procedure, with gastric bypass for morbid obesity; with short limb (150 cm or less) Roux-en-Y gastroenterostomy. |
| 43847 | Gastric restrictive procedure, with small intestine reconstruction to limit absorption. |
| 43846 | Open gastric bypass |
| 43644 | Laparoscopic gastric bypass |
| 43770 | Laparoscopic adjustable gastric banding |
| 43775 | Open or laparoscopic sleeve gastrectomy |
| 43842 | Vertical-banded gastroplasty |
| 43999 | Unlisted procedure, stomach |
| 0312T | Previously included CPT code (removed effective 01/01/23) - listed in historical notes |
| 0313T | Previously included CPT code (removed effective 01/01/23) - listed in historical notes |
| 0314T | Previously included CPT code (removed effective 01/01/23) - listed in historical notes |
| 0315T | Previously included CPT code (removed effective 01/01/23) - listed in historical notes |
| 0316T | Previously included CPT code (removed effective 01/01/23) - listed in historical notes |
| 0317T | Previously included CPT code (removed effective 01/01/23) - listed in historical notes |
| 43290 | New CPT code added |
| 43291 | New CPT code added |
| 43889 | New CPT code added effective 01/01/26 |
| 0813T | CPT code added (noted in 01/01/24 update) |
Prior Authorization, Documentation, and Provider Requirements
Procedure prior authorization required
Prior authorization is required for bariatric procedures when coverage exists; requests must reference the applicable CPT/HCPCS code(s) listed in the policy and include supporting clinical documentation that medical necessity criteria are met.
- Prior authorization applies to the covered and investigational procedure codes listed in the policy (see coding tables).
- Authorization requests must include documentation that medical necessity criteria are satisfied (BMI, comorbidities, weight-loss program participation, mental health clearance).
Prior authorization for listed procedure codes
Submit a prior authorization request for any of the bariatric CPT/HCPCS codes enumerated in the policy (including covered, investigational, and unlisted codes referenced for SADI‑S).
Authorization must reference planned procedural code
When requesting authorization, reference the specific bariatric CPT code for the planned operation; the policy explicitly notes authorization is relevant for listed CPT codes and for the unlisted stomach code 43999 used for SADI‑S.
- Do not substitute an incorrect CPT; use 43999 only when no specific CPT exists (e.g., SADI‑S) and include detailed operative description.
- Prior authorization should identify the exact procedure (open vs laparoscopic; short‑limb vs long‑limb as applicable).
Include BMI and comorbidity documentation
Authorization requests must include objective BMI evidence and documentation of obesity‑related comorbidities aligned with the policy selection criteria (e.g., BMI thresholds and listed comorbid conditions).
- Document measured BMI that meets the policy threshold (e.g., ≥40 kg/m2; 35–39.9 kg/m2 with at least one obesity‑related comorbidity; or 30–34.9 kg/m2 with T2D and inadequate glycemic control).
- Include clinical records demonstrating the specific comorbidity(ies) cited in the policy (e.g., coronary heart disease, uncontrolled hypertension, T2D with HbA1c≥7).
Device‑specific prior authorization considerations
If an implantable or temporary bariatric device is planned, prior authorization must reflect device‑specific labeled indications and limits and include device identity and intended use.
- Confirm and document device brand/model and FDA‑labeled indications (examples: Spatz3, Obalon, ORBERA, AspireAssist, LAP‑BAND, REALIZE) and maximum placement durations as applicable.
- Provide evidence of failure of supervised weight‑loss programs when required by the device labeling.
Evidence referenced for prior authorization
The policy cites the CMS Decision Memo and other guideline and evidence sources; prior authorization determinations are informed by these references but the policy requires clinical documentation per its stated criteria.
- References include CMS Decision Memo (CAG‑00250R) and multiple guideline and evidence citations supporting coverage decisions.
- Use cited guidelines/evidence to support that clinical criteria are met when submitting authorization documentation.
Prior authorization — follow current coding notes
Prior authorization requests should use the medical policy’s current CPT/HCPCS code list; coding updates and additions in the coding section must be used when requesting authorization.
- Verify codes against the policy coding section (new and terminated codes are noted, e.g., addition of 43889; termination of C9784 effective 01/01/26).
- Include any updated or unlisted codes referenced in the policy history when applicable to the planned procedure.
Conservative management documentation (≥3 months)
Document participation in a physician‑administered weight‑reduction program of at least three continuous months within the 12 months before surgery; records must show active participation.
- Include program duration (≥3 continuous months) and evidence of active participation such as weight logs, current dietary program, and physical activity documentation.
- Alternatively, document participation in a structured weight‑loss program (e.g., Weight Watchers, Jenny Craig) supervised by the healthcare provider.
Document failure of conservative therapy
Prior authorization requires documentation that conservative (nonsurgical) weight‑reduction measures were attempted and failed before bariatric surgery is considered.
- Provide records of prior dietary and lifestyle interventions and practitioner review of these attempts.
- For adjustable gastric banding and other procedures, document postoperative compliance history if prior procedures were performed.
Conservative therapy prerequisite
Documented failure of conservative measures (dietary and lifestyle changes) is expected and should be available with the authorization request.
- Evidence may include weight history, program participation records, and clinician notes reviewing previous nonsurgical interventions.
Document medical therapy tried for Class I obesity with T2D
For adults with BMI 30–34.9 kg/m2 and type 2 diabetes, authorization should document inadequate glycemic control despite optimal lifestyle interventions and medical therapy (e.g., HbA1c ≥7).
- Include recent HbA1c values (showing ≥7) and documentation of trials of lifestyle modification and antidiabetic medications.
- State rationale that medical therapy and lifestyle efforts were insufficient to achieve glycemic control.
Intragastric balloon preconditions for authorization
For temporary intragastric balloon therapies, prior authorization must document prior supervised weight‑loss program attempts and adherence to device maximum placement durations per device labeling.
- Document that the patient failed supervised weight‑loss programs and confirm intended balloon maximum placement duration (e.g., 6–8 months depending on device).
- Include device model and labeled population (BMI ranges) to support authorization.
No additional step therapy specified
No formal step‑therapy protocol (beyond the conservative management and documentation requirements) is specified in the references section of this policy.
- Policy specifies required conservative program participation and failure of nonsurgical measures but does not list additional step therapy sequences.
Certain authorization details not explicitly described
Some procedural or administrative details are not explicitly described in the references section of this policy; follow the policy’s documentation and coding guidance when submitting authorization.
- When in doubt, include full clinical documentation and consult member benefits for plan‑specific limits.
- The policy history and references may clarify code status and past policy changes but are not a substitute for current required documentation.
Required clinical documentation for authorization
Medical records submitted for authorization must document BMI meeting policy criteria, relevant comorbid conditions, completion of a physician‑administered weight‑loss program, and mental health evaluation and clearance.
- Include measured BMI (not self‑reported) with date, documentation of comorbidities listed in the policy, and evidence of a supervised weight‑loss program of ≥3 months within 12 months prior to surgery.
- Attach a licensed mental health provider’s evaluation and explicit clearance; a letter from a non‑mental‑health provider alone is insufficient.
Preoperative EGD documentation requirements
If preoperative esophagogastroduodenoscopy (EGD) is performed, include the indication, findings, classifications used, and an explanation of how findings changed surgical planning or management.
- Document symptoms or clinical indications prompting EGD, EGD findings with standard terminology/classifications, and whether findings altered or delayed the planned procedure.
- For EGD surveillance (e.g., after sleeve gastrectomy), document timing and plan for follow‑up per ASMBS guidance (e.g., ≥3 years post‑SG and ~every 5 years thereafter as reasonable).
Preoperative evaluation documentation to include weight‑related complications
Preoperative evaluation documentation must record weight‑related complications, causes of obesity, justification for offering surgery, and readiness for surgery.
- Include assessment of comorbid conditions (e.g., T2D, OSA, NASH), prior weight‑loss attempts, and the clinical rationale for the chosen bariatric procedure.
- Document multidisciplinary evaluations and any adolescent‑specific readiness criteria when applicable.
EGD documentation for surgical planning and surveillance
Document EGD findings to detect contraindications (e.g., malignancy, large hiatal hernia, peptic ulcer, H. pylori) that would affect procedure selection and to support surveillance plans.
- Record timing of EGD relative to surgery and any preoperative treatment instituted based on findings.
- For sleeve gastrectomy patients, include plans for EGD surveillance per ASMBS recommendations if applicable.
Guidelines and position statements may support documentation
The policy cites multiple guidelines and position statements (ASMBS, AGA, IFSO, SAGES, CMS) that inform preoperative evaluation and documentation; providers may include such guideline references to support authorization when relevant.
- Cited guidance may be used to justify indicated preoperative testing (e.g., selective EGD) and documentation choices.
- Reference the guideline or position statement in the clinical rationale when it directly supports the requested procedure.
Member benefit verification required
Verify member benefits and plan‑specific coverage limits before submitting authorization — member contracts may exclude bariatric services or impose limitations.
- Consult the member benefit booklet or contact customer service to confirm eligibility and any contract age or benefit limitations.
- Coverage is subject to the member's specific plan; this medical policy does not apply to Medicare Advantage.
Denial risk for BMI below coverage thresholds or missing documentation
Authorization will be denied when BMI and clinical thresholds in the policy are not met (e.g., BMI <35 kg/m2 without T2D) or when required documentation is missing.
- Do not request authorization for patients with BMI below policy thresholds unless the patient meets an allowed exception (e.g., Asian‑specific thresholds documented in the record).
- Missing documentation of BMI, comorbidities, or required conservative management participation may trigger denial.
Denial risk when revision requested for noncompliance
Requests for revision or conversion solely because of individual noncompliance with postoperative nutrition and exercise are not considered medically necessary and may be denied.
- If revision is for inadequate weight loss, document objective failure (failure to lose ≥50% EBW or <20% TWL) and evidence of postoperative compliance unless revision is for a complication.
- Noncompliance alone is not an acceptable indication for revision authorization.
Denial risk: missing preoperative program or mental health documentation
Incomplete documentation of required preoperative items (structured weight‑loss program participation, mental health evaluation and clearance, or BMI/comorbidity evidence) is a common trigger for denial.
- Ensure structured program participation and active engagement are documented (weight, diet, activity records) and include licensed mental health clearance.
- Authorization reviewers will check that conservative therapy attempts were reviewed by the practitioner prior to approval.
Denial risk for routine preoperative EGD without indication
Routine preoperative EGD performed without documented symptoms or clinical indication may be considered discretionary and could be unsupported by guideline recommendations, risking denial for routine EGD requests.
- ASMBS recommends preoperative EGD for symptomatic individuals and otherwise leaves routine EGD to surgeon discretion; document clear clinical indication if requesting authorization for preoperative EGD.
- Systematic reviews reported that only about one‑fifth of EGDs find issues that alter operative management; justify routine EGD if included in the request.
Low‑yield EGD: risk of non‑coverage without clear indication
Routine preoperative esophagogastroduodenoscopy (EGD) has limited yield; lack of evidence that routine EGD alters management in most patients may lead to denial of routine EGD unless a documented indication exists.
- Provide documentation of symptoms, abnormal findings on clinical exam, or other indications if requesting preoperative EGD authorization.
- If EGD is performed to inform surgical selection, include how findings affected management.
Contraindications and denial risk
Do not authorize bariatric surgery for patients with listed contraindications (e.g., preadolescent children, pregnant or breastfeeding adolescents or those planning pregnancy within two years, unresolved substance abuse, eating disorder, or untreated psychiatric disorder); such conditions may justify denial.
- Document resolution of substance use, eating disorders, or psychiatric disorders and demonstrate mastery of healthy dietary and activity habits before requesting authorization.
- Adhere to adolescent‑specific requirements (Tanner stage, family stability, pediatric center capabilities) when applicable.
References do not replace authorization requirements
The references section does not itself provide separate authorization actions; use the policy’s prior authorization and documentation requirements when preparing requests.
- References support the policy but do not replace explicit documentation requirements listed in the policy sections.
- Follow the policy documentation checklist rather than relying on references alone for authorization submissions.
Denial risk for unmet medical necessity criteria
Failure to meet the policy’s medical necessity criteria (selection and preoperative requirements) can result in non‑coverage; when reoperation criteria are met, the policy no longer requires meeting initial selection criteria again.
- Provide evidence that the patient meets the applicable selection criteria or the reoperation criteria as described in the policy.
- For reoperation where medical necessity criteria under reoperation are met, do not resubmit initial selection criteria unnecessarily.
Background and Scope
Bariatric surgery is an established intervention for clinically severe (morbid) obesity and related comorbidities when conservative measures fail. Procedures are designed to produce sustained weight loss through restrictive and/or malabsorptive mechanisms, can improve obesity‑related conditions, and require careful patient selection, multidisciplinary preoperative evaluation, and long‑term follow‑up to manage surgical risks and nutritional needs.
Definitions and Key Terms
Policy Revision History
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.